Senile Osteoporotic Fractures Cohort Study(SOFCS)

Sponsor
Suzhou Municipal Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05848167
Collaborator
(none)
2,000
1
36
55.6

Study Details

Study Description

Brief Summary

Osteoporotic fracture is one of the main causes of disability and death in elderly patients. Specific disease cohort study is an important basis for accurate prevention and treatment of senile osteoporotic fractures. Investigators plan to collect and manage the baseline and clinical information of more than 2000 elderly patients with osteoporotic fractures after surgery through the platform of special disease collaborative prevention and treatment system and medical record database of Suzhou Municipal Hospital in two years, and carry out short-term and long-term follow-up observation.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Osteoporotic fracture is one of the main causes of disability and death in elderly patients. Compared with patients with no history of fractures, the risk of a second fracture after an initial fracture doubled, with a fatality rate of up to 34.8%. There has been a lot of progress in the diagnosis and treatment of osteoporotic fractures in the elderly. However, there are few reports on the diagnosis and treatment of osteoporotic fractures in the elderly after surgery. Based on previous studies, it is found that the re-fracture after operation of osteoporotic fracture in the elderly is not only directly caused by the fall, but also caused by the interaction of multiple risk factors including environmental factors, physiological factors and neuroskeletal musculoskeletal system. Therefore, it is of great significance to break the traditional diagnosis and treatment mode, improve the diagnosis and treatment effect, and save medical resources to carry out research on the disease characteristics, rules and risk warning after senile osteoporotic fracture operation. Specific disease cohort study is an important basis for accurate prevention and treatment of senile osteoporotic fractures. Investigators plan to collect and manage the baseline and clinical information of more than 2000 elderly patients with osteoporotic fractures after surgery through the platform of special disease collaborative prevention and treatment system and medical record database of Suzhou Municipal Hospital in two years, and carry out short-term and long-term follow-up observation.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    2000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Senile Osteoporotic Fractures Cohort Study
    Actual Study Start Date :
    Jul 15, 2021
    Anticipated Primary Completion Date :
    Jul 14, 2023
    Anticipated Study Completion Date :
    Jul 14, 2024

    Outcome Measures

    Primary Outcome Measures

    1. Bone mineral density [two years]

      BMD

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    65 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. Patients ≥65 years old

    2. Patients with osteoporosis

    3. No gender limitation

    Exclusion Criteria:
    1. < 65 years old;

    2. Non-osteoporotic fracture;

    3. Alzheimer's disease;

    4. Bone tumors.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Suzhou Municipal Hospital Suzhou Jiangsu China 215000

    Sponsors and Collaborators

    • Suzhou Municipal Hospital

    Investigators

    • Study Chair: Hao Y feng, doctor, Suzhou Municipal Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Mo Zhou, Director, Suzhou Municipal Hospital
    ClinicalTrials.gov Identifier:
    NCT05848167
    Other Study ID Numbers:
    • GSKY20210404
    First Posted:
    May 8, 2023
    Last Update Posted:
    May 8, 2023
    Last Verified:
    May 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Mo Zhou, Director, Suzhou Municipal Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 8, 2023